Robert Langer
Affiliations
- at Seer Inc. (SEER), 2024-06-14
- Director at Moderna Inc. (MRNA), 2024-05-07
- Director at Frequency Therapeutics Inc. (FREQ), 2022-08-19
- Large Shareholder at Sqz Biotechnologies Co (SQZ), 2020-10-30
- Director at Lyra Therapeutics Inc. (LYRA), 2020-05-06
- Director at Rubius Therapeutics Inc. (RUBY), 2019-10-17
- Director at Kala Pharmaceuticals Inc. (KALA), 2018-06-15
- Director at Abpro Corp (ABP), 2018-05-11
- Director at Dnib Unwind Inc. (BIND), 2016-08-30
- Large Shareholder at Selecta Biosciences Inc (SELB), 2016-06-21
- Director at Ocata Therapeutics Inc. (OCAT), 2016-02-11
- Large Shareholder at Invivo Therapeutics Holdings Corp. (NVIV), 2013-06-05
- Director at Fibrocell Science Inc. (NONE), 2011-01-18
- Director at Millipore Corp (MIL), 2010-07-16
- Director at Echo Therapeutics Inc. (ECTE), 2010-04-30
- Director at Wyeth (WYE), 2009-10-19
Insider Trading: Sales See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
RUBY | $8.52 | 7,500 | $63,874.50 | 0 | 2019-10-14 | Filing |
RUBY | $14.94 | 7,500 | $112,048.50 | 0 | 2019-07-15 | Filing |
RUBY | $17.57 | 7,500 | $131,799.00 | 0 | 2019-04-15 | Filing |
RUBY | $14.59 | 7,500 | $109,443.75 | 0 | 2019-01-14 | Filing |
NVIV | $3.91 | 2,500 | $9,775.00 | 7,433,628 | 2013-06-05 | Filing |